ArticleCellular & molecular biology letters2023

Empagliflozin improves renal ischemia-reperfusion injury by reducing inflammation and enhancing mitochondrial fusion through AMPK-OPA1 pathway promotion.

Wenbo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.